How Giordano was paid
$8.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Christopher T. GiordanoPresident and Chief Executive Officer | $563,734 | $7,266,000 | $204,375 | $45,524 | $8,079,633 |
| Stuart RichChief Medical Officer | $322,724 | $3,242,750 | $157,500 | $9,993 | $3,732,967 |
| Thomas A. McGauleyInterim Chief Financial Officer | — | — | — | $475,498 | $475,498 |
What changed and why
- $8.1MChristopher T. Giordano total compensation increased to $8,079,633 in fiscal year 2025.
- 75%Operational goals for 2025 were achieved at 75% resulting in lower non-equity incentive payouts.
- Named executive officers were compensated through base salary, annual cash bonuses, and stock options.
- $475KThomas A. McGauley received $475,498 in consulting fees for interim financial services.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.